Ledger.Open graph →
SEC Form D · filed May 4, 2020

Artax Biopharma, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert M. Armstrong, Ph.D · Cambridge, MADirectorJoseph M. Lobacki · Cambridge, MAExec · DirectorDamia M. Tormo, Ph.D · Cambridge, MADirectorAlan E. Walts · Cambridge, MADirectorGino M. Santini · Cambridge, MADirectorJavier M. Garcia · Cambridge, MADirectorEdwin Kania · LOS ANGELES, CADirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorKen Deregt · New York, NYDirectorMark Reynoso · LOS ANGELES, CAExec · DirectorIhor Lys · LOS ANGELES, CADirectorQuentin Yarie · Toronto, Ontario, CanadaDirectorArne Brock-Utne · Lafayette, CADirectorWarren A. Heffelfinger · Lafayette, CAExec · DirectorDerek T. Yoon · Gaithersburg, MDDirectorRami Elghandour · Gaithersburg, MDDirectorDavid T. Lubner · Gaithersburg, MDDirectorAlan Young · Detroit, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗